556 related articles for article (PubMed ID: 31314062)
1. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
2. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
Armer JM; Ballman KV; McCall L; Armer NC; Sun Y; Udmuangpia T; Hunt KK; Mittendorf EA; Byrd DR; Julian TB; Boughey JC
Support Care Cancer; 2019 Feb; 27(2):495-503. PubMed ID: 29980907
[TBL] [Abstract][Full Text] [Related]
3. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
4. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
[TBL] [Abstract][Full Text] [Related]
6. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
Jia M; Pan L; Yang H; Gao J; Guo F
Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
[TBL] [Abstract][Full Text] [Related]
7. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
9. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
10. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
11. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
13. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
14. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer-Related Lymphedema.
Montagna G; Zhang J; Sevilimedu V; Charyn J; Abbate K; Gomez EA; Mehrara B; Morrow M; Barrio AV
JAMA Oncol; 2022 Aug; 8(8):1195-1200. PubMed ID: 35679026
[TBL] [Abstract][Full Text] [Related]
16. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant systemic therapy for breast cancer: the Westmead experience.
Cocco AM; Messer D; Brown A; Sriram N; Gilchrist J; Al-Mansouri L; Kefford R; Meybodi F; French J; Hsu J; Elder E
ANZ J Surg; 2018 Jun; 88(6):640-644. PubMed ID: 28922685
[TBL] [Abstract][Full Text] [Related]
18. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients.
Martelli G; Boracchi P; Orenti A; Lozza L; Maugeri I; Vetrella G; Agresti R
Eur J Surg Oncol; 2014 Jul; 40(7):805-12. PubMed ID: 24768443
[TBL] [Abstract][Full Text] [Related]
19. Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
El Hage Chehade H; Headon H; El Tokhy O; Heeney J; Kasem A; Mokbel K
Am J Surg; 2016 Nov; 212(5):969-981. PubMed ID: 27671032
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
